title: Subcutaneous administration of loxapine.
authors.affiliation: Vancouver General Hospital, British Columbia, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Sauder
authors.forename: P
authors.initials: P
authors.lastname: Porterfield
authors.forename: K F
authors.initials: KF
authors.lastname: Shalansky
authors.forename: K L
authors.initials: KL
authors.lastname: Tong
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008152:Loxapine / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods
chemical_list: D014150:Antipsychotic Agents; D008152:Loxapine